In a new study described by one oncologist as "seminal" and "pioneering", researchers in the United States have successfully used CRISPR gene-editing technology to create personalized cancer-targeting ...

Companies that hope to treat severe inherited diseases via CRISPR genome editing are already testing the technique in adults, while push-the-envelope types are arguing for repairing defective genes ...

Editas Medicine, Inc. EDIT announced data from the phase I/II BRILLIANCE study evaluating its lead pipeline candidate, EDIT-101, for treating blindness due to Leber congenital amaurosis type 10 (LCA10 ...